Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8541457
APP PUB NO 20100152187A1
SERIAL NO

11916243

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I), where V, W, R1, R2, R3 and R4 are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XENON PHARMACEUTICALS INC200 - 3650 GILMORE WAY BURNABY B C V5G 4W8

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fu, Jianmin Coquitlam, CA 85 814
Hou, Duanjie Burnaby, CA 27 386
Kamboj, Rajender Burnaby, CA 82 842
Kodumuru, Vishnumurthy Burnaby, CA 39 499
Pokrovskaia, Natalia New Westminster, CA 15 76
Raina, Vandna Burnaby, CA 21 355
Sun, Shaoyi Coquitlam, CA 71 908
Sviridov, Serguei Burnaby, CA 46 665
Zhang, Zaihui Vancouver, CA 67 611

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 24, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00